Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$170M Hold
67,294,884
3.16% 3
2025
Q4
$225M Hold
67,294,884
4.03% 3
2025
Q3
$258M Hold
67,294,884
4.36% 3
2025
Q2
$289M Hold
67,294,884
6.2% 2
2025
Q1
$264M Hold
67,294,884
5.68% 2
2024
Q4
$342M Hold
67,294,884
7.58% 2
2024
Q3
$478M Hold
67,294,884
8.15% 2
2024
Q2
$383M Hold
67,294,884
8.45% 2
2024
Q1
$500M Buy
67,294,884
+1,566,519
+2% +$13.1M 15.22% 2
2023
Q4
$609M Buy
65,728,365
+33,256,346
+102% +$246M 15.77% 2
2023
Q3
$218M Hold
32,472,019
7.27% 2
2023
Q2
$309M Hold
32,472,019
34.18% 2
2023
Q1
$305M Buy
32,472,019
+15,806,037
+95% +$163M 100% 1
2022
Q4
$139M Buy
+16,665,982
New +$156M 100% 1

Other funds holding CLVT

Exor N.V.'s CLVT Position: Q1 2026 in Review

Exor N.V. held its Clarivate (CLVT) position steady in Q1 2026 at 67,294,884 shares worth $170M. The position accounts for 3.16% of the portfolio, ranked #3.

Exor N.V. first reported a position in CLVT in Q4 2022 and has held it in 14 quarters since. The position peaked at $609M in Q4 2023. 255 funds tracked by Wall St. Rank hold CLVT as of Q1 2026.

  • Exor N.V. held 67,294,884 shares of Clarivate worth $170M as of Q1 2026.
  • Exor N.V. left its Clarivate share count unchanged in Q1 2026.
  • Clarivate made up 3.16% of Exor N.V.'s portfolio in Q1 2026, its #3 holding.
  • Exor N.V. first reported a position in Clarivate in Q4 2022 and has held it in 14 quarters since.
  • Exor N.V.'s Clarivate position peaked at $609M in Q4 2023.
  • 255 funds tracked by Wall St. Rank held Clarivate as of Q1 2026.

Based on Exor N.V.'s 13F filing for Q1 2026, filed 13 May 2026.